Polycystic ovary syndrome renamed after decade of global consultation
The Story
Polycystic ovary syndrome (PCOS) has been renamed to polyendocrine metabolic ovarian syndrome (PMOS) following more than a decade of global consultation. The condition, which affects as many as one in eight women, is caused by high levels of androgens and can lead to symptoms such as excess hair, weight gain and irregular periods.
Key Facts
- The condition previously known as polycystic ovary syndrome has been renamed polyendocrine metabolic ovarian syndrome (PMOS).
- The renaming followed more than a decade of global consultation.
- PCOS affects as many as one in eight women.
- The condition is caused by high levels of androgens.
- Symptoms include excess hair, weight gain, and irregular periods.
- Campaigners had wanted the condition renamed, according to the source.
Conflicting Reports
No conflicting reports identified in the source article.
Still Unclear
No open questions identified in the source article.
Misconceptions
No widespread misconceptions addressed in the source article.
Key Figures
- Nicola Davis – The Guardian’s science correspondent (mentioned in the podcast description)
- Rachel – a campaigner from the charity Verity
Sources: The Guardian
